Bibliografía_TFM_Los psicofármacos se sitúan como la cuarta droga de prevalencia en nuestro país

Autor: Asociación Proyecto Hombre      20/07/2022     

Arria, M., Caldeira, K., Vincent, K., O’Grady, K., Cimini, M., Geisner, I., Fossos-Wong, N., Kilmer, J. y Larimer, M. (2017). Do college students improve their grades by using precription stimulants nonmedically. Addictive Behaviors, 65, 245-249. https://doi.org/10.1016/j.addbeh.2016.07.016

Back, S., Payne, R., Simpson, A y Brady, K. (2010). Gender and prescription opioids: Findings from the National Survey on Drug and Health. Addictive Behaviors, 35(11), 1001-1007. https://doi.org/10.1016/j.addbeh.2010.06.018

Carmona, J., Maxwell, J., Park, J. y Wu, L. (2020). Prevalence and health characteristics of prescription opioid use, misuse, and use disorders among U.S adolescents. Adolescent health and medicine, 66(5), 536-534.

Carrassco-Garrido, P., Díaz, D., Jiménez-Trujillo, I., Hernández-Barrera, V., Lima, L., Palacios-Ceña, D. (2020). Patterns of non-medical use of benzodiazepines and Young adults: gender differences and related factors. Journal of Substance Use, 26(2), 190-196. https://doi.org/10.1080/14659891.2020.1800846

Carrassco-Garrido, P., Díaz, D., Jiménez-Trujillo, I., Hernández-Barrera, V., Lima, L., Palacios-Ceña, D. (2021). Nonmedical use of benzodiazepines among immigrant and native-born adolescents in Spain: National Trends and related factors. Environmental Research and Public Health, 18(3), 1-8.

Carrasco-Garrido, P., Jiménez-Trujillo, I., Hernández-Barrera, V., Garcia-Gómez-Heras, S., Alonso-Fernández, N. y Palacios-Ceña, D. (2019). Trends in the misuse of tranquilizers, sedatives and sleeping pills by adolescents in Spain: 2004-2014. Journal of adolescents health, 63(6), 709-716.

Catalano, R, White, H, Fleming, C y Haggerty, K (2011). ¿Is nonmedical prescription opiate use a unique form of illicit drug use?. Addictive Behaviors, 36(1-2), 76-86. https://doi.org/10.1016/j. addbeh.2010.08.028

Cho, J., Kelley-Quon, L., Barrington-Trimis, J., Kechter, A., Axeen, S. y Leventhal, A. (2021). Behavioral health risk factors for nonmedical prescription opioid use in adolescence. Pediatrics, 148(3), 1-11. https://doi.org/10.1542/peds.2021-051451

Groenewald, C., Patel, K., Rabbits, J., y Palermo, T. (2019). Correlates and motivations of prescription opioid use among adolescents 12-17 years of age in the United States. Pain, 161(4), 742-748. https://doi.org/10.1097/j.pain.0000000000001775

Hachtel, J., y Amstrong, K. (2019). Illicit use of prescription stimulants: gender

differences in perceptions of risk. Substance use & misuse, 54(10), 1654-1662.

Friedrich, J., Sun, C., Geng, X., Calello, D., Gillam, M., Medeiros, K., Smith, M., Ruck, B. y Mazer-Amirshahi, M. (2019). Child and adolescent benzodiazepine

exposure and overdose in the United States: 16 years of poison center data.

Clinical Toxicology, 1–7. https://doi.org/10.1080/15563650.2019.1674321

Kecojevic, A., Wong, C., Corliss, H., Lankenau, S. (2015). Risk factors for high levels of precription drug misuse and ilicit drug use among substance-using Young men who have sex with men. Drug and Alcohol Dependence, 150, 156-163, https://doi.org/ 10.1016/j.drugalcdep.2015.02.031

Lee, J. y Thrul, J., (2021). Trends in opioid misuse by cigarette smoking status among US adolescents: results from national survey on drug use and health 2015-1018. Preventive medicine, 153, 1-7. https://doi.org/10.1016/j.ypmed.2021.106829

McCabe, S., Schulenberg, J., McCabe, V. y Veliz, P. (2020). Medical use and misuse of prescription opioids in US 12th-Grade Youth: School-Level Correlates. Pediatrics, 146(4), 1-11. https://doi.org/10.1542/peds.2020-022798

McCabe, S., Wilens, T., Boyd, C., Chua, K., Voepel-Lewis, T y Schepis, T. (2019). Age-specific risk of substance use disorders associated with controlled

 medication use and misuse subtypes in the United States. Addictive Behaviors, 90, 285-293. https://doi.org/10.1016/j.addbeh.2018.11.010

Montiel, F., McNab, P., Gilreath, T., Sameron, B. y Williams, F. (2020). A

comprehensive multivariate model of biopsychosocial factors associated with

opioid misuse and use disorder in a 2017-2018 United States national survey.

BMC Public Health, 20(1), 1-16. https://doi.org/10.1186/s12889-020-09856-2

Moreta-Herrera, R., Mayorga-Lascano, M., León-Tamayo, L y Ilaja-Verdesoto, B. (2017). Consumo de sustancias legales, ilegales y fármacos en adolescentes y factores de riesgo asociados a la exposición reciente. Health and Addictions, 18(1), 39-50.

Perlmutter, A., Rivera-Aguirre, A., Mauro, P., Castillo-Carniglia, A., Rodriguez, N., Cadenas, N., Cerdà, M. y Martins, S. (2019). Sex differences in nonmedical

prescription tranquilizer and stimulant use trends among secondary school

students in Argentina, Chile and Uruguay. Drug and alcohol dependence, 205.

https://doi.org/ 10.1016/j.drugalcdep.2019.107607

Plan Nacional sobre Drogas. (2021). INFORME 2020 Alcohol, tabaco y drogas ilegales en España. Encuesta sobre uso de drogas en Enseñanzas Secundarias en España (ESTUDES), 1994-2018/2019. https://pnsd.sanidad.gob.es/

Rabinowitz, J., Reboussin, B., Thrul, J., Drabick, D., Khan, G., Green, K., Ialongo, N., Huhn, A. y Maher, B. (2021). Early childhood behavioral and academic antecedents of lifetime opioid misuse among urban youth. Journal of clinical child and adolescent psychology, 53, 1-13.

Restar, A., Jin, H., Ogunbajo, A., Goedel, W., Millett, G., Sherwood, J., Kuhns, L., Reisner, S., Garofalo, R. y Mimiaga, M., (2020). Prevalence and Risk Factors of nonmedical prescription opioid use among transgender girls and young women. JAMA, 3(3). https://doi.org/ 10.1001/jamanetworkopen.2020.1015

Schepis, T., Teter, C., Simoni-Wastila, L. y McCabe, S. (2018). Prescription

tranquilizer/sedative misuse prevalence and correlates across age cohorts in the US. Addictive Behaviors, 87, 24-32.

Steiger, R., Stoddard, S. y Pierce, J. (2017). Adolescent’s future orientations and nonmedical use of prescription drugs. Addictive Behaviors, 65, 269-274.

Striley, C., Kelso-Chichetto, N., y Cottler, L. (2017). Nonmedical prescription stimulant among girls 10-18 years of age: associations with other risky behavior. Adolescent health, 60(3), 328-332.

Tucker, J., Davis, J., Seelam, R., Stein, B. y D’Amico, E. (2020) Predictors of opioid misuse during emerging adulthood: an examination of adolescent individual, family and peer factor. Drug and Alcohol Dependence, 214, 1-6.

Weidberg, S., Aonso-Diego, G., García-Fernández, G. y Secades-Villa, R. (2022) Prevalence and correlates of prescription drug misuse among Spanish

adolescents. Psicothema, 34(2), 275-282. https://doi.org/10.7334/psicothema2021.389

Wilson, A., Morasco, B., Holley, A. y Edwing, S. (2020). Patterns of opioid use in adolescents receiving prescriptions: The role of psychological and pain factors. American Psychologist, 75(6), 748-760. https://doi.org/10.1037/amp0000697